Whole-body biodistribution and radiation dosimetry of [18F]PR04.MZ: a new PET radiotracer for clinical management of patients with movement disorders
Conclusion[18F]PR04.MZ has a favourable dosimetry profile, comparable to those of other18F-labelled PET tracers, and is suitable for larger clinical applications.Trial registration CEC SSM Oriente, Santiago, Chile, permit 20140520.
Source: EJNMMI Research - Category: Radiology Source Type: research
More News: Brain | Chile Health | CT Scan | Liver | Neurology | Parkinson's Disease | PET Scan | Radiology | Study | Urology & Nephrology